- Generic name
- Tofacitinib
- Strength
- 5 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
INJAK 5 TABLET Tablet
About INJAK 5 TABLET
INJAK 5 TABLET is a tablet from The ACME Laboratories Ltd., with the generic name Tofacitinib. It is not a painkiller for everyday aches, and it should not be started without a doctor's assessment.
There are 13 brands of Tofacitinib listed in Bangladesh. The lowest listed price is Tofacit 5 mg Tablet at ৳ 30.00 per unit.
What is INJAK 5 TABLET?
Made by The ACME Laboratories Ltd., INJAK 5 TABLET is a tablet whose active ingredient is Tofacitinib. The body's immune system uses signalling pathways to drive inflammation, and Tofacitinib interferes with that process. Tofacitinib belongs to a group of medicines called immunosuppressants. Ask your doctor or pharmacist if you are unsure about it.
Uses of INJAK 5 TABLET
It is not a painkiller for everyday aches, and it should not be started without a doctor's assessment. It is an immunosuppressant medicine, so it is meant for people whose condition has been assessed by a doctor. INJAK 5 TABLET is used for adults with moderately to severely active rheumatoid arthritis whose earlier treatment with methotrexate did not work well enough or was not tolerated. Your doctor will decide if this medicine is suitable for you.
How to use INJAK 5 TABLET
INJAK 5 TABLET 5 mg tablet is taken by mouth. Swallow the tablet with water. Shake the bottle well before each use. The dose and course are decided by your doctor based on your condition and other medicines you take. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of INJAK 5 TABLET
Common side effects reported during the first three months of treatment include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis. Ask the doctor or pharmacist about anything you notice. Tell your doctor promptly about fever, persistent cough, or any sign of infection. Tell your doctor right away if you develop signs of infection such as fever, cough, or persistent sore throat.
Safety and precautions
It is used with caution in people who may be at increased risk of gastrointestinal perforation. It is not known whether Tofacitinib passes into human milk, so breastfeeding decisions need medical advice. Your doctor may monitor your blood counts, liver enzymes, and lipids. Tell your doctor about infections, kidney or liver problems, pregnancy, planning pregnancy or breastfeeding before starting.
Frequently asked questions
What is INJAK 5 TABLET used for?
It is not a painkiller for everyday aches, and it should not be started without a doctor's assessment. It is an immunosuppressant medicine, so it is meant for people whose condition has been assessed by a doctor.
How is INJAK 5 TABLET used?
INJAK 5 TABLET 5 mg tablet is taken by mouth. Swallow the tablet with water.
Can INJAK 5 TABLET cause side effects?
Common side effects reported during the first three months of treatment include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis. Ask the doctor or pharmacist about anything you notice.
Who should be careful with INJAK 5 TABLET?
It is used with caution in people who may be at increased risk of gastrointestinal perforation. It is not known whether Tofacitinib passes into human milk, so breastfeeding decisions need medical advice.
Indications
Psoriatic Arthritis: Tofacitinib is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Ulcerative Colitis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
Pharmacology
Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and activation of STATs. The JAK-STAT signalling pathway is involved in the transcription of cells involved in hematopoiesis, and immune cell function. Tofacitinib works therapeutically by inhibiting the JAK-STAT pathway to decrease the inflammatory response. However, there is evidence to suggest that it may also achieve efficacy via other pathways as well.
Dosage & Administration
Psoriatic Arthritis (in combination with nonbiologic DMARDs): Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.
Ulcerative Colitis: Tofacitinib 10 mg twice daily for at least 8 weeks; then 5 or 10 mg twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to maintain response.
Interaction
- Potent inhibitors of Cytochrome P450 3A4 (CYP3A4) (e.g., Ketoconazole)
- Recommended dose is Tofacitinib 5 mg once daily: One or more concomitant medications that result in both moderate inhibition of CYP3A4 and potent inhibition of CYP2C19 (e.g., fluconazole)
- Recommended dose is Tofacitinib 5 mg once daily Potent CYP inducers (e.g.Rifampin): May result in loss of or reduced clinical response.
Side Effects
Pregnancy & Lactation
It is not known whether Tofacitinib is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Tofacitinib, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug for the mother
Precautions & Warnings
- Serious Infections: Avoid use of Tofacitinib during an active serious infection, including localized infections.
- Gastrointestinal Perforations: Use with caution in patients that may be at increased risk.
- Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.
- Immunizations: Live vaccines: Avoid use with Tofacitinib.
- Do not initiate Tofacitinib if absolute lymphocyte count <500 cells/mm3, an absolute neutrophil count (ANC) <1000 cells/mm3 or hemoglobin <9 gm/dL.
Storage Conditions
Alternative brands of Tofacitinib
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.